| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054623 | Oral Oncology | 2016 | 13 Pages |
Abstract
It is feasible to generate DCs from the PBMCs and isolate ALDHhigh CSCs from cultured tumor cells of the patients with HNSCC to prepare CSC-DC vaccines that can induce anti-HNSCC CSC cellular and humoral immunity, indicating its potential clinical application to treat patients with HNSCC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Mark E.P. Prince, Li Zhou, Jeffrey S. Moyer, Huimin Tao, Lin Lu, John Owen, Martin Egenti, Fang Zheng, Alfred E. Chang, Jianchuan Xia, Gregory Wolf, Max S. Wicha, Shiang Huang, Xiubao Ren, Qiao Li,